Coronavirus-positive Nasopharyngeal Aspirate as Predictor for Severe Acute Respiratory Syndrome Mortality
2003

Predicting SARS Mortality with Nasopharyngeal Aspirate

Sample size: 218 publication 10 minutes Evidence: moderate

Author Information

Author(s): Tsang Owen Tak-Yin, Chau Tai-Nin, Choi Kin-Wing, Tso Eugene Yuk-Keung, Lim Wilina, Chiu Ming-Chi, Tong Wing-Lok, Lee Po-Oi, Lam Bosco Hoi Shiu, Ng Tak-Keung, Lai Jak-Yiu, Yu Wai-Cho, Lai Sik-To

Primary Institution: Princess Margaret Hospital, Hong Kong

Hypothesis

Is a positive RT-PCR result on nasopharyngeal aspirate samples an independent predictor of death in SARS patients?

Conclusion

A positive RT-PCR result on nasopharyngeal aspirate samples is an independent predictor of higher mortality in SARS patients.

Supporting Evidence

  • 156 out of 218 patients tested positive for coronavirus.
  • Patients with positive RT-PCR results had higher rates of ICU admission and mechanical ventilation.
  • The overall 30-day mortality rate was 10.1%.

Takeaway

If a patient has a positive test for the coronavirus in their nose, they are more likely to get very sick and might not survive.

Methodology

The study compared symptoms and outcomes of 218 patients with suspected SARS, using RT-PCR to test nasopharyngeal aspirate samples.

Potential Biases

Potential for mislabeling non-SARS patients as SARS due to nonspecific symptoms.

Limitations

The study may not account for all variables affecting mortality, and the timing of sample collection could influence RT-PCR results.

Participant Demographics

Majority were Chinese, with a mean age of 39.6 years; included 90 males and 128 females.

Statistical Information

P-Value

0.038

Confidence Interval

1.1 to 38.0

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3201/eid0911.030400

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication